H.814 establishes a new state policy framework around “neurological rights” and the use of artificial intelligence in health care, human services, education, and certain government functions. The bill states legislative intent to promote ethical, responsible, transparent, and accountable AI use while improving access, efficiency, quality of care, and outcomes. It also creates a new chapter in Title 18 recognizing individual rights to mental and neural data privacy, freedom of thought, nondiscrimination in neurotechnology, control over decisions about neurotechnology, and protection from unauthorized access, manipulation, or alteration of brain activity and mental functions.
The bill also updates the Artificial Intelligence Advisory Council in Title 3, expanding its membership to include representatives with expertise in ethics and human rights, health care, education, racial equity, public finance, and other relevant fields. The council is directed to work with the Division of Artificial Intelligence to review AI systems used in state government, conduct public outreach and education, and study ethical AI use in health care, human services, education, public participation, and public finance. It must report to the General Assembly by January 15, 2027 with recommendations for additional statutory changes, including definitions and protections for neurological rights, guidance on generative AI in regulated professions, and regulation of AI in health insurance utilization review.
The bill’s impact on state law is to create a formal legal recognition of neurological rights and to broaden state oversight of artificial intelligence policy. It amends existing law governing the Artificial Intelligence Advisory Council and extends the council’s sunset date to June 30, 2030, while requiring a report on whether that sunset should be delayed further or removed. It does not itself impose detailed operational rules on AI use, but instead sets up a structure for future policy development, pilot projects, and possible regulation in health insurance, public engagement, and professional practice.
The general sentiment reflected in the bill text is strongly supportive of AI governance, patient protection, and ethical oversight. The measure frames AI as something that can improve services and outcomes if used responsibly, but also as a source of potential harm that requires safeguards. Because no committee transcripts or recorded votes were provided, there is no direct evidence of opposition or support from legislators in the available context.
The main points of potential contention are likely to be the scope of the new neurological rights, the regulation of neurotechnology and generative AI, and the possibility of future restrictions on AI in health insurance utilization review and regulated professions. Questions may also arise about how broadly the state should define mental and neural privacy, how enforceable these rights would be, and whether the expanded advisory council and reporting requirements are sufficient or too open-ended. The bill appears designed to invite further study and stakeholder input rather than settle those policy disputes immediately.
The bill adds a new chapter to Title 18 recognizing neurological rights and amends Title 3 to expand and extend the Artificial Intelligence Advisory Council. It affects state government AI oversight, health care, human services, education, public participation, and public finance by directing study, outreach, and future recommendations rather than immediate substantive regulation. It also creates a policy foundation for possible future statutes on neurotechnology, generative AI, and insurance utilization review.
The bill is framed in strongly affirmative terms, emphasizing ethical use, transparency, accountability, equity, and protection from harm. Its structure suggests a broad policy consensus around the need for oversight of AI in sensitive public and health-related settings, while also acknowledging that the technology may provide benefits. No votes or committee testimony were provided, so the available record does not show formal support or opposition beyond the bill’s own policy framing.
Likely areas of contention include how far “neurological rights” should extend, whether the state should regulate neurotechnology at all, and how aggressively AI should be constrained in health insurance, professional practice, and government decision-making. Stakeholders with interests in health care, human services, education, public finance, and AI development may differ on the need for binding rules versus advisory study. The bill’s reliance on a future report also suggests unresolved debate over definitions, enforcement, and the appropriate balance between innovation and protection.